管理贫血:心力衰竭和慢性病的融合点?
Oana Nicoleta Buliga-Finis1,2, Anca Ouatu1,2, Daniela Maria Tanase1,2
1Department of Internal Medicine, "Grigore T. Popa" University of Medicine and Pharmacy, 700115 Iasi, Romania.
Life (Basel, Switzerland)
|June 28, 2023
概括
心力衰竭 (HF) 和慢性病 (CKD) 患者的贫血,称为心脏脏贫血综合征 (CRSA),是常见和复杂的. 像HIF-PH抑制剂这样的新兴疗法提供了新的治疗途径.
科学领域:
- 心脏病学 心脏病学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 血液学 血液学 血液学
背景情况:
- 慢性心力衰竭综合征 (CRS) 涉及慢性心力衰竭 (HF) 和慢性病 (CKD) 之间的复杂相互作用.
- 贫血是CRS中普遍存在的并发症,影响5%至55%的晚期HF和CKD患者.
- 贫血通过减少氧气运输和组织缺氧等机制加剧心脏和功能障碍.
研究的目的:
- 审查当前和新兴的治疗策略,以管理患有心血管贫血综合征 (CRSA) 的患者的贫血.
- 探索超越传统的血红蛋白集中治疗的新疗法.
主要方法:
- 本综述综合了近期临床试验和关于CRS背景下贫血的研究结果.
- 它检查了连接HF,CKD和贫血的生理病理机制.
主要成果:
- 贫血的患病率随着HF和CKD的严重程度而增加.
- 关键的机制包括降低红色素的产生和氧气运输受损,导致缺氧和恶化心功能.
- 新的治疗药物,包括低氧诱导因子-基酶 (HIF-PH) 抑制剂和肝素抗剂,显示出希望.
结论:
- 由于CRSA的高发病率和死亡率,它带来了重大挑战.
- 针对HIF-PH通路和肝素的新型治疗剂在CRSA管理中提供了潜在的进步.
- 需要进一步的研究来确定这些新疗法的疗效和安全性.
相关概念视频
Chronic Kidney Disease IV: Nursing Management
29
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
29
Heart Failure VI: Adjunct Therapies
16
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
16
Heart Failure VII: Nursing Interventions
111
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
111
Chronic Kidney Disease III: Interprofessional Care
48
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
48
Heart Failure V: Medical Management
15
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
15
Heart Failure Drugs: Diuretics
425
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
425


